O
Oriol Gasch
Researcher at Autonomous University of Barcelona
Publications - 56
Citations - 1536
Oriol Gasch is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Methicillin-resistant Staphylococcus aureus & Medicine. The author has an hindex of 19, co-authored 46 publications receiving 1149 citations. Previous affiliations of Oriol Gasch include University of Barcelona & Bellvitge University Hospital.
Papers
More filters
Journal ArticleDOI
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez,Elena Salamanca,Marina de Cueto,Po-Ren Hsueh,Pierluigi Viale,José Ramón Paño-Pardo,Mario Venditti,Mario Tumbarello,George L. Daikos,Rafael Cantón,Yohei Doi,Felipe Francisco Tuon,Ilias Karaiskos,Elena Pérez-Nadales,Mitchell J. Schwaber,Mitchell J. Schwaber,Özlem Kurt Azap,Maria Souli,Emmanuel Roilides,Spyros Pournaras,Murat Akova,Federico Perez,Joaquín Bermejo,Antonio Oliver,Manel Almela,Warren Lowman,Benito Almirante,Robert A. Bonomo,Robert A. Bonomo,Yehuda Carmeli,Yehuda Carmeli,David L. Paterson,Álvaro Pascual,Álvaro Pascual,Jesús Rodríguez-Baño,Jesús Rodríguez-Baño,M.D. del Toro,Jorge Galvez,Marco Falcone,Alessandro Russo,Helen Giamarellou,Enrico Maria Trecarichi,Angela Raffaella Losito,E. García-Vázquez,Alicia Hernandez,J. Gómez,Germán Bou,Elias Iosifidis,N. Prim,Ferran Navarro,Beatriz Mirelis,Anna Skiada,Julia Origüen,R. San Juan,Mario Fernández-Ruiz,Nieves Larrosa,Mireia Puig-Asensio,José Miguel Cisneros,José Molina,V. González,V. Rucci,E. Ruiz de Gopegui,C. I. Marinescu,Luis Martínez-Martínez,M.C. Fariñas,M. E. Cano,Mónica Gozalo,Marta Mora-Rillo,C. Navarro-San Francisco,Carmen Peña,Silvia Gómez-Zorrilla,Fe Tubau,Athanassios Tsakris,O. Zarkotou,Anastasia Antoniadou,Garyphallia Poulakou,Johann D. D. Pitout,Deepali Virmani,J. Torre-Cisneros,Julia Guzmán-Puche,Ö. Helvaci,A. O. Sahin,Vicente Pintado,Patricia Cordero Ruiz,Michele Bartoletti,Maddalena Giannella,Evelina Tacconelli,F. Riemenschneider,Esther Calbo,Cristina Badia,M. Xercavins,Oriol Gasch,D. Fontanals,E. Jové +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.
Belén Gutiérrez-Gutiérrez,Salvador Pérez-Galera,Elena Salamanca,Marina de Cueto,Esther Calbo,Benito Almirante,Pierluigi Viale,Antonio Oliver,Vicente Pintado,Oriol Gasch,Luis Martínez-Martínez,Johann D. D. Pitout,Murat Akova,Carmen Peña,José Molina,Alicia Hernandez,Mario Venditti,Núria Prim,Julia Origüen,Germán Bou,Evelina Tacconelli,Mario Tumbarello,Axel Hamprecht,Helen Giamarellou,Manel Almela,Federico Perez,Mitchell J. Schwaber,Joaquín Bermejo,Warren Lowman,Po-Ren Hsueh,Marta Mora-Rillo,Clara Natera,Maria Souli,Robert A. Bonomo,Robert A. Bonomo,Yehuda Carmeli,David L. Paterson,Álvaro Pascual,Jesús Rodríguez-Baño +38 more
TL;DR: BLBLIs, if active in vitro, appear to be as effective as carbapenems for ET and TT of BSI due to ESLB-E regardless of the source and specific species.
Journal ArticleDOI
Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
Oriol Gasch,Mariana Camoez,María Ángeles Domínguez,Belén Padilla,Vicente Pintado,Benito Almirante,José Molina,Francisco López-Medrano,Elena Ruiz Ruiz,J A Martínez,Elena Bereciartua,Fernando Rodríguez-López,Carlos Fernández-Mazarrasa,Miguel Ángel Goenaga,Natividad Benito,Jesús Rodríguez-Baño,Elena Espejo,Miquel Pujol +17 more
TL;DR: A prospective study in a large cohort of patients with MRSA-BSI from 21 Spanish hospitals found initial therapy was appropriate in 66% of episodes and V-MIC ≥1.5 did not have a significant impact on mortality, regardless of the method used to assess it.
Journal ArticleDOI
Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial
Ana del Río,Oriol Gasch,Oriol Gasch,Asunción Moreno,Carmen Peña,Jordi Cuquet,Dolors Soy,Carlos A. Mestres,Cristina Suárez,J.C. Paré,Fe Tubau,Cristina Garcia de la Maria,Francesc Marco,Jordi Carratalà,José M. Gatell,Francisco Gudiol,José M. Miró,Juan M. Pericàs,Carlos Cervera,Yolanda Armero,Manel Almela,David Fuster,Ramón Cartañá,Salvador Ninot,Manel Azqueta,Marta Sitges,Magda Heras,José L. Pomar,José Ramírez,Mercè Brunet,Jaume Llopis,Miquel Pujol,Javier Ariza,Carmina Martí,Mireia Mijana +34 more
TL;DR: Fosfomycin plus imipenem was an effective and safe combination when used as rescue therapy for complicated MRSA bloodstream infections and deserves further clinical evaluation as initial therapy in these infections.
Journal ArticleDOI
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.
Miquel Pujol,Miró Jm,Evelyn Shaw,José María Aguado,Rafael San-Juan,Mireia Puig-Asensio,Carles Pigrau,Esther Calbo,Miguel Montejo,Regino Rodriguez-Alvarez,María-Jose Garcia-Pais,Vicente Pintado,Rosa Escudero-Sánchez,Joaquín López-Contreras,Laura Morata,Milagros Montero,Marta Andrés,Juan Pasquau,María-Del-Mar Arenas,Belén Padilla,Javier Murillas,Alfredo Jover-Sáenz,Luis-Eduardo López-Cortes,G. García-Pardo,Oriol Gasch,Sebastián Videla,Pilar Hereu,Cristian Tebé,Natalia Pallares,Mireia Sanllorente,María-Ángeles Domínguez,Jordi Càmara,Anna Ferrer,Ariadna Padullés,Guillermo Cuervo,Jordi Carratalà,Mrsa Bacteremia (Bacsarm) Trial Investigators +36 more
TL;DR: Daptomycin plus fosfomycin provided 12% higher rate of treatment success than daptomecin alone, but this difference did not reach statistical significance.